PedAM
Pediatric Disease Annotations & Medicines
| Disease | asthma |
| Phenotype | C0010674|cystic fibrosis |
| Sentences | 8 |
| PubMedID- 24420817 | Successfully diagnosing concomitant asthma in people with cystic fibrosis (cf) is a challenging proposition, and the utility of conventional diagnostic criteria of asthma in cf populations remains uncertain. |
| PubMedID- 24915624 | It usually affects asthmatics and patients with cystic fibrosis. |
| PubMedID- 22591432 | asthma, allergy with superinfection, cystic fibrosis, intubated ventilation, burn injuries, and medication-induced complications are discussed in this paper. |
| PubMedID- 24727374 | Dysregulation of the competing enzymes has been shown to contribute to airway obstruction in asthma and in patients with cystic fibrosis [3–5]. |
| PubMedID- 23204847 | Since 2001, omalizumab (xolair, genentech, novartis, south san francisco, ca) has been a useful treatment for moderate to severe allergic asthma, but limited literature exists on its use in abpa with bronchial asthma in patients without cystic fibrosis (cf).6–8 in 2007, we presented preliminary data on three patients with treatment-resistant abpa (ie, those with corticosteroid-dependent disease), who were treated with omalizumab with improvement regarding quality of life symptoms, medication usage and pulmonary function testing.9 recently, case reports of patients with cystic fibrosis and abpa and adult asthmatics with abpa have suggested that omalizumab, a recombinant anti-immunoglobulin e, might be effective for treating acute exacerbations and reducing systemic corticosteroid requirements.7–13 we sought to clarify whether omalizumab is a useful adjunctive therapy for adult asthmatics with abpa. |
| PubMedID- 21625309 | In humans who are immunocompromised these saprophytic fungi can cause life-threatening invasive aspergillosis and, in asthmatics and those with cystic fibrosis, allergic disease (allergic bronchopulmonary aspergillosis (abpa)). |
| PubMedID- 23632183 | Inhaled hypertonic saline+hyaluronic acid in cystic fibrosis with asthma-like symptoms: a new therapeutic chance. |
| PubMedID- 26063959 | The present review identified the analysis of ve/vco2 in situations regarding healthy children, asthmatic children, children with cystic fibrosis, cardiovascular disease, obese children, adolescents in puberty, premature babies, neurological diseases, and sickle cell disease (scd) and was also used as a method of evaluation, monitorization, and prognosis, as discussed below. |
Page: 1